richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine..español..

here are 4 mass. biotechs making noise at the ash conference so far..

... https://drbryanpwalsh.com/Schoewe-father-of-Hottman-from-Coimbra?Sturmsist=135 .

.

daily pilot.

eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention...

all programs

.
.
hin - ??????